271 related articles for article (PubMed ID: 33386412)
1. Efficacy and safety of atrial septal defect closure using Occlutech Figulla Flex II compared with Amplatzer Septal Occluder.
Nakayama R; Takaya Y; Akagi T; Watanabe N; Miki T; Nakagawa K; Toh N; Ito H
Heart Vessels; 2021 May; 36(5):704-709. PubMed ID: 33386412
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.
Godart F; Houeijeh A; Recher M; Francart C; Polge AS; Richardson M; Cajot MA; Duhamel A
Arch Cardiovasc Dis; 2015 Jan; 108(1):57-63. PubMed ID: 25453168
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects.
Kenny D; Eicken A; Dähnert I; Boudjemline Y; Sievert H; Schneider MB; Gori T; Hijazi ZM;
Catheter Cardiovasc Interv; 2019 Feb; 93(2):316-321. PubMed ID: 30719850
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure.
Roymanee S; Promphan W; Tonklang N; Wongwaitaweewong K
Pediatr Cardiol; 2015 Jun; 36(5):935-41. PubMed ID: 25633819
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance of Septal Malalignment for Transcatheter Closure of Atrial Septal Defect.
Takaya Y; Akagi T; Nakagawa K; Nakayama R; Miki T; Watanabe N; Toh N; Ito H
J Interv Cardiol; 2020; 2020():6090612. PubMed ID: 32206044
[TBL] [Abstract][Full Text] [Related]
6. Appropriate device selection for transcatheter atrial septal defect closure using three-dimensional transesophageal echocardiography.
Kitakata H; Itabashi Y; Kanazawa H; Miura K; Kimura M; Shinada K; de Jongh MC; Endo J; Tsuruta H; Murata M; Kawamura A; Murata M; Fukuda K
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1159-1168. PubMed ID: 33151513
[TBL] [Abstract][Full Text] [Related]
7. Cobrahead Deformity in the Right Atrial Disc of a New-Generation Occlutech Figulla Flex II Atrial Septal Defect Occluder Device.
Kilic T; Ural E; Sahin T
Tex Heart Inst J; 2015 Oct; 42(5):454-7. PubMed ID: 26504440
[TBL] [Abstract][Full Text] [Related]
8. Comparing the Performance of Amplatzer® and Occlutech® Figulla® Septal Occluders: The Pediatric Point of View. A Retrospective Study.
Nir-David Y; Mainzer G; Tal R; Lorber A
Isr Med Assoc J; 2017 Sep; 19(9):557-561. PubMed ID: 28971639
[TBL] [Abstract][Full Text] [Related]
9. Figulla ASD occluder versus Amplatzer Septal Occluder: a comparative study on validation of a novel device for percutaneous closure of atrial septal defects.
Pac A; Polat TB; Cetin I; Oflaz MB; Balli S
J Interv Cardiol; 2009 Dec; 22(6):489-95. PubMed ID: 19735475
[TBL] [Abstract][Full Text] [Related]
10. Safety of Occlutech Septal Occluder ACCELL Flex II for Transcatheter Closure of Secundum Atrial Septal Defects in Children: A Long-Term Follow-Up.
El-Sisi AM; El-Saiedi SA; Ammar R; Abdelhameed A; Hijazi ZM; Soliman MM
J Interv Cardiol; 2022; 2022():8886813. PubMed ID: 35069039
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of an atrial septal defect with high risk of erosion using a Figulla Flex II atrial septal defect occluder.
Tada N; Mizutani Y; Matsumoto T; Sakurai M; Ootomo T
Cardiovasc Interv Ther; 2017 Oct; 32(4):436-439. PubMed ID: 28108954
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
13. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of Cardi-O-Fix septal occluder versus Amplatzer septal occluder in percutaneous closure of secundum atrial septal defects.
Saritas T; Kaya MG; Lam YY; Erdem A; Akdeniz C; Demir F; Erol N; Demir H; Celebi A
Catheter Cardiovasc Interv; 2013 Jul; 82(1):116-21. PubMed ID: 21805616
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up.
Snijder RJR; Renes LE; Bosshardt D; Suttorp MJ; Ten Berg JM; Post MC
J Interv Cardiol; 2020; 2020():7136802. PubMed ID: 32140088
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Figulla Flex® and Amplatzer™ devices for atrial septal defect closure: A meta-analysis.
Aparisi A; Arnold RJ; Gutiérrez H; Revilla A; Serrador A; Ramos B; Rodriguez-Gabella T; Campo A; Baladrón C; Gómez I; Carrasco-Moraleja M; San Roman JA; Amat-Santos IJ
Cardiol J; 2020; 27(5):524-532. PubMed ID: 32329042
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter closure of secundum ASD using Occlutech Figulla-N device in symptomatic children younger than 2 years of age.
Ammar RI; Hegazy RA
J Invasive Cardiol; 2013 Feb; 25(2):76-9. PubMed ID: 23388225
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized trial of transthoracic echocardiography versus transesophageal echocardiography for assessment and guidance of transcatheter closure of atrial septal defects in children using the Amplatzer septal occluder.
Bartakian S; El-Said HG; Printz B; Moore JW
JACC Cardiovasc Interv; 2013 Sep; 6(9):974-80. PubMed ID: 24050864
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter Closure of an Atrial Septal Defect.
Ueda H
Intern Med; 2022 Jan; 61(1):1-2. PubMed ID: 33583908
[No Abstract] [Full Text] [Related]
20. [Transcatheter closure of secundum atrial septal defect in children].
Gao W; Zhou AQ; Yu ZQ; Li F; Zhang YQ; Sun K; Zhong YM
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):287-90. PubMed ID: 15157392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
